Abstract

Introduction

It is important to determine those clinical factors that imply a greater risk of rehospitalization in psychotic patients

Objectives

To determine the rate and predictors of rehospitalization in psychotic patients after their first hospitalization

Methods

We include all Psychotic patients admitted for first time in their life in our Psychiatric Unit between 2009 and 2019 (N=359) , including all diagnosed according DSM-IV of Schizophrenia or other Psychotic disorders -Multiple clinical, sociodemographic and biological variables of the basal hospitalization were recorded With the SPSS program we compared the variables between patients who needed any hospitalization in the follow-up until 31th December 2019 and those who do not. We use the Chi square ( qualitative variables) and the Student T ( quantitative variables)

Results

109 psychotic inpatients had at least one rehospitalizations (30,4%). The qualitative variables significantly associated with rehospitalization were : cannabis in urine at admission (P<0.03), and treatment with risperidone (P<0.014). Instead treatment with long acting paliperidone was associated with absence of rehospitalization (P<0.005) .The quantitative variables relationed significantly with multiple rehospitalization were : lower age (P<0,015) lower HDL cholesterol levels (P<0.02) and higher years of follow-up after discharge (P<0.000)

Conclusions

1-More of 30% of psychotic patients need rehospitalization after their first hospitalization in a mean of follow up of 5,8 years 2-Lower age, longer follow-up period and treatment with risperidone are significantly associated with rehospitalization , instead treatment with long acting paliperidone are significantly associated with absence of rehospitalization

Disclosure

No significant relationships.

Details

Title
Predictors of rehospitalization in Psychotic Patients after their first hospitalization
Author
Álvarez, P 1 ; Palau, A 2 ; Russo, C 2 ; Nieto, E 2 

 Fundació Althaia Xarxa Assistencial of Manresa, Psychiatry, Manresa, Spain; Fundaciò Althaia Xarxa Assistencial of Manresa, Psychiatry, Manresa (Barcelona), Spain 
 Fundació Althaia Xarxa Assistencial of Manresa, Psychiatry, Manresa, Spain 
Pages
S676-S676
Publication year
2022
Publication date
Jun 2022
Publisher
Cambridge University Press
ISSN
09249338
e-ISSN
17783585
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2708671529
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.